EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of RNAscope for HPV mRNA detection in liquid-based cervical cytology samples

Tianqi Liu, Xianrong Zhou, Xiang Tao, Hao Zhang, Tingting Chen

Frontiers in Oncology · 11.03.2026 · 16

DOI: 10.3389/fonc.2026.1766237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 11.03.2026. Verfasst von Tianqi Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of …. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To establish an RNAscope-based joint detection scheme compatible with liquid-based cytology (LBC) slides and staining systems, enabling simultaneous observation of cytological phenotype and HPV E6/E7 mRNA expression in cervical cancer and precancerous lesions.

Methods

From March 2023 to February 2024, 115 LBC samples were collected at the Affiliated Obstetrics and Gynecology Hospital of Fudan University. Histopathological diagnosis included 30 LSIL, 33 HSIL, 29 HPV-related SCC, 8 HPV-related adenocarcinoma and 15 negative for cervical intraepithelial lesions cases. RNAscope technology, originally applied to paraffin samples, was adapted for LBC by modifying slide type selection, extending target retrieval, and enhancing permeabilization. The improved RNAscope in situ hybridization was then employed to detect high-risk HPV E6/E7 mRNA. Positive rates, diagnostic concordance with histopathology and, expression pattern were statistically analyzed.

Results

RNAscope combined with LBC showed high positive rates, 93.33% for LSIL, 96.97% for HSIL, 100.00% for SCC, and 87.50% for HPV-related adenocarcinoma. Compared with HPV PCR testing, the diagnostic concordance rate reached 95.65% (P<0.001). Figures illustrate RNAscope positive expression patterns in LSIL, HSIL, SCC and, HPV-related adenocarcinoma.

Conclusion

The adaptation of RNAscope technology, originally designed for paraffin samples, enables accurate diagnosis in cervical LBC, enhances consistency with histopathology, and provides a novel diagnostic approach for cervical lesions.

Schlagwörter

Stichwörter der Autor:innen

HPV E6/E7 mRNARNAscopecervical lesionin situ Hybridizationliquid-based cytology

Autor:innen und Institutionen

  • Department of Pathology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.

Zitieren

APA

Liu, T., Zhou, X., Tao, X., Zhang, H., & Chen, T. (2026). Optimization of RNAscope for HPV mRNA detection in liquid-based cervical cytology samples. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1766237

Vancouver

Liu T, Zhou X, Tao X, Zhang H, Chen T. Optimization of RNAscope for HPV mRNA detection in liquid-based cervical cytology samples. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1766237

BibTeX
@article{Liu2026,
  author = {Liu, Tianqi and Zhou, Xianrong and Tao, Xiang and Zhang, Hao and Chen, Tingting},
  title = {Optimization of RNAscope for HPV mRNA detection in liquid-based cervical cytology samples},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1766237}
}
Kostenlos starten →